HOLLYWOOD, Calif., March 11, 2013 /PRNewswire/ — Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing industry specific consulting services and patented systems to various medical and retail related industries worldwide, announced that the company’s CEO, Dr. Bruce Bedrick, will be featured on Fox Business Channel twice this week.
“We are absolutely thrilled to be appearing on Fox Business Channel to discuss our past, present, and future endeavors in both the medical marijuana compliance industry and the traditional pharmaceutical dispensing market,” Dr. Bedrick stated. “We believe providing safe, effective, compliant, and cost effective solutions for pharmacies, hospitals, urgent care centers, prisons, hospice facilities, dispensaries, and rehabilitation clinics worldwide helps solve inherent problems that currently exist within these same institutions. These interviews are just one part of what will be an ongoing effort to tell this story and keep the public informed.”
A schedule of the appearances is listed below:
Monday, March 11
“Varney & Co”
With Host Stuart Varney
9:45 a.m. EDT
Friday, March 15
With Hosts Melissa Francis / Lori Rothman
1:30 p.m. EDT
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.
Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.
Medbox, Inc. is a publicly traded company, and is listed on the OTC Markets, ticker symbol MDBX.
For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are made in accordance with the Private Securities Litigation Reform Act of 1995. Our actual results may differ materially from those implied in these forward-looking statements as a result of many factors. Forward-looking statements speak only as of the date they are made. We undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur.